Ghrelin: More than endogenous growth hormone secretagogue

Annals of the New York Academy of Sciences

Volumn 1200, Issue , 2010, Pages 140-148

  Kojima, Masayasu ^a   Kangawa, Kenji ^b  

^a KURUME UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

appetite regulation; ghrelin; growth hormone releasing

Indexed keywords

GHRELIN; GROWTH HORMONE SECRETAGOGUE;

CONFERENCE PAPER; ENERGY CONSERVATION; FEEDING BEHAVIOR; FOOD INTAKE; MOUSE; NONHUMAN; PHENOTYPE; PRADER WILLI SYNDROME; PROTEIN ANALYSIS;

EID: 77954591294     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05516.x     Document Type: Conference Paper

References (46)

1. Kojima, M. et al. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 : 656 660.
2. Litwack, G ed.). 2008. Ghrelin. Academic Press.
3. Kojima, M. K. Kangawa. 2005. Ghrelin: structure and function. Physiol. Rev. 85 : 495 522.
4. Kojima, M. et al. 2001. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metab. 12 : 118 122. (Pubitemid 33714199)
5. Kojima, M., T. Ida T. Sato. 2008. Structure of mammalian and nonmammalian ghrelins. Vitam. Horm. 77 : 31 46.
6. Zhu, X. et al. 2006. On the processing of proghrelin to ghrelin. J. Biol. Chem. 281 : 38867 38870.
7. Walia, P. et al. 2009. Ontogeny of ghrelin, obestatin, preproghrelin, and prohormone convertases in rat pancreas and stomach. Pediatr. Res. 65 : 39 44.
8. Gutierrez, J.A. et al. 2008. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl. Acad. Sci. USA 105 : 6320 6325.
9. Yang, J. et al. 2008. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132 : 387 396.
10. Sakata, I. et al. 2009. Co-localization of ghrelin O-acyltransferase (GOAT) and ghrelin in gastric mucosal cells. Am. J. Physiol. Endocrinol. Metab. 297 : E134 E141.
11. Kaiya, H. et al. 2001. Bullfrog ghrelin is modified by n-octanoic acid at its third threonine residue. J. Biol. Chem. 276 : 40441 40448.
12. Ohgusu, H. et al. 2009. Ghrelin O-acyltransferase (GOAT) has a preference for n-hexanoyl-CoA over n-octanoyl-CoA as an acyl donor. Biochem. Biophys. Res. Comm. 386 : 153 158.
13. Date, Y. et al. 2002. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123 : 1120 1128.
14. Sakata, I. et al. 2003. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci. Lett. 342 : 183 186.
15. Zhang, W. et al. 2004. Ghrelin stimulates neurogenesis in the dorsal motor nucleus of the vagus. J. Physiol. 559 : 729 737.
16. Date, Y. et al. 2001. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem. Biophys. Res. Commun. 280 : 904 907.
17. Williams, D.L. et al. 2003. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology 144 : 5184 5187.
18. Date, Y. et al. 2006. Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus. Cell Metab. 4 : 323 331.
19. Minokoshi, Y. et al. 2004. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428 : 569 574.
20. Xue, B. B.B. Kahn. 2006. AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J. Physiol. 574 : 73 83.
21. Andersson, U. et al. 2004. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279 : 12005 12008.
22. Lopez, M. et al. 2008. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab. 7 : 389 399.
23. Kola, B. et al. 2005. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J. Biol. Chem. 280 : 25196 25201.
24. Andrews, Z.B. et al. 2008. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 454 : 846 851.
25. Sato, T. et al. 2008. Ghrelin deficiency does not influence feeding performance. Regul. Pept. 145 : 7 11.
26. Sun, Y., S. Ahmed R.G. Smith. 2003. Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell Biol. 23 : 7973 7981.
27. Wortley, K.E. et al. 2004. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc. Natl. Acad. Sci. USA 101 : 8227 8232.
28. Erickson, J.C., K.E. Clegg R.D. Palmiter. 1996. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381 : 415 421.
29. Qian, S. et al. 2002. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol. Cell Biol. 22 : 5027 5035.
30. Sun, Y. et al. 2008. Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology 149 : 843 850.
31. Sun, Y. et al 2004. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. USA 101 : 4679 4684.
32. Youm, Y.H. et al. 2009. Deficient ghrelin receptor-mediated signaling compromises thymic stromal cell microenvironment by accelerating thymic adiposity. J. Biol. Chem. 284 : 7068 7077.
33. Ariyasu, H. et al. 2005. Transgenic mice overexpressing des-acyl ghrelin show small phenotype. Endocrinology 146 : 355 364.
34. Iwakura, H. et al. 2005. Analysis of rat insulin II promoter-ghrelin transgenic mice and rat glucagon promoter-ghrelin transgenic mice. J. Biol. Chem. 280 : 15247 15256.
35. Bewick, G.A. et al. 2009. Mice with hyperghrelinemia are hyperphagic and glucose intolerant and have reduced leptin sensitivity. Diabetes 58 : 840 846.
36. Corbetta, S. et al. 2003. Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J. Clin. Endocrinol. Metab. 88 : 3117 3120.
37. Tsolakis, A.V. et al. 2004. Malignant gastric ghrelinoma with hyperghrelinemia. J. Clin. Endocrinol. Metab. 89 : 3739 3744.
38. Nicholls, R.D. J.L. Knepper. 2001. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet. 2 : 153 175.
39. Cummings, D.E. et al. 2002. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat. Med. 8 : 643 644.
40. DelParigi, A. et al. 2002. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome. J. Clin. Endocrinol. Metab. 87 : 5461 5464.
41. Feigerlova, E. et al. 2008. Hyperghrelinemia precedes obesity in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 93 : 2800 2805.
42. Ding, F. et al. 2008. SnoRNA Snord116 (Pwcr1/MBII-85) deletion causes growth deficiency and hyperphagia in mice. PLoS ONE. 3 : e1709.
43. Date, Y. et al. 2002. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 51 : 124 129.
44. Heller, R.S. et al. 2005. Genetic determinants of pancreatic epsilon-cell development. Dev. Biol. 286 : 217 224.
45. Prado, C.L. et al. 2004. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc. Natl. Acad. Sci. USA 101 : 2924 2929.
46. Doyle, M.J., Z.L. Loomis L. Sussel. 2007. Nkx2.2-repressor activity is sufficient to specify alpha-cells and a small number of beta-cells in the pancreatic islet. Development 134 : 515 523.